sodium bisulfide has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, W; Bi, F; Hao, Y; Li, H; Liu, X; Xu, X; Yang, Q; Yang, R | 1 |
| Huang, Z; Li, X; Lin, J; Lin, Y; Wu, W | 1 |
2 other study(ies) available for sodium bisulfide and Diabetic Angiopathies
| Article | Year |
|---|---|
Involvement of amylin B-H2S-connexin 43 signaling pathway in vascular dysfunction and enhanced ischemia-reperfusion-induced myocardial injury in diabetic rats.
Topics: Amylin Receptor Agonists; Animals; Carbenoxolone; Connexin 43; Diabetic Angiopathies; Diabetic Cardiomyopathies; Disease Models, Animal; Hydrogen Sulfide; Islet Amyloid Polypeptide; Isolated Heart Preparation; Male; Mesenteric Arteries; Myocardial Reperfusion Injury; Myocardium; Rats, Wistar; Signal Transduction; Sulfides; Vasodilation | 2020 |
Exogenous sodium hydrosulfide protects against high glucose‑induced injury and inflammation in human umbilical vein endothelial cells by inhibiting necroptosis via the p38 MAPK signaling pathway.
Topics: Cell Survival; Cells, Cultured; Diabetic Angiopathies; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Interleukin-8; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Necroptosis; p38 Mitogen-Activated Protein Kinases; Protective Agents; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Sulfides; Tumor Necrosis Factor-alpha | 2021 |